News + Filings Holdings
|
SILVERARC CAPITAL MANAGEMENT, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
ImmunoGen, Inc.
| IMGN | COM | 1,420,000 | 1,270,000 | 26,795,400,000 | 26,219,400,000 | 8.29 | 0.63 |
Hist
| 06/30/2023 |
Merus N.V.
| MRUS | COM | 589,255 | -79,529 | 15,515,084,000 | 3,209,458,000 | 4.80 | |
Hist
| 06/30/2023 |
Morphic Holding, Inc.
| MORF | Common | 252,309 | 200,625 | 14,464,875,000 | 12,519,489,000 | 4.47 | 0.64 |
Hist
| 06/30/2023 |
Schrodinger, Inc.
| SDGR | Common | 286,169 | 73,344 | 14,285,556,000 | 8,681,874,000 | 4.42 | 0.40 |
Hist
| 06/30/2023 |
Krystal Biotech, Inc.
| KRYS | Common | 118,941 | 84,927 | 13,963,673,000 | 11,240,512,000 | 4.32 | 0.46 |
Hist
| 06/30/2023 |
Intra-Cellular Therapies, Inc.
| ITCI | Common | 198,723 | 73,688 | 12,583,140,000 | 5,812,495,000 | 3.89 | |
Hist
| 06/30/2023 |
Akero Therapeutics, Inc.
| AKRO | Common | 241,357 | 38,796 | 11,268,958,000 | 3,518,974,000 | 3.49 | 0.48 |
Hist
| 06/30/2023 |
Oric Pharmaceuticals, Inc.
| ORIC | Common | 1,450,822 | 14,877 | 11,258,379,000 | 3,073,492,000 | 3.48 | 3.22 |
Hist
| 06/30/2023 |
Akero Therapeutics, Inc.
| AKRO | Call | 236,500 | 236,500 | 11,039,820,000 | 11,039,820,000 | 3.41 | |
Hist
| 06/30/2023 |
MoonLake Immunotherapeutics
| MLTX | Common | 200,000 | 94,250 | 10,200,000,000 | 7,938,007,000 | 3.16 | 0.38 |
Hist
| 06/30/2023 |
BIOGEN INC.
| BIIB | Common | 26,854 | 15,543 | 7,649,362,000 | 4,504,565,000 | 2.37 | |
Hist
| 06/30/2023 |
89bio, Inc.
| ETNB | Common | 396,497 | -41,718 | 7,513,618,000 | 839,604,000 | 2.32 | |
Hist
| 06/30/2023 |
Cogent Biosciences, Inc.
| COGT | Common | 620,000 | 40,736 | 7,340,800,000 | 1,090,541,000 | 2.27 | 0.87 |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | Call | 651,400 | 0 | 6,755,018,000 | 1,485,192,000 | 2.09 | |
Hist
| 06/30/2023 |
UNITED THERAPEUTICS Corp
| UTHR | Common | 30,029 | 11,451 | 6,628,902,000 | 2,468,173,000 | 2.05 | 0.06 |
Hist
| 06/30/2023 |
MACROGENICS INC
| MGNX | Common | 1,215,675 | -146,134 | 6,503,861,000 | -3,260,310,000 | 2.01 | 1.97 |
Hist
| 06/30/2023 |
KalVista Pharmaceuticals, Inc.
| KALV | Common | 720,508 | -3,036 | 6,484,572,000 | 797,516,000 | 2.01 | 2.10 |
Hist
| 06/30/2023 |
VERACYTE, INC.
| VCYT | Common | 229,451 | 19,798 | 5,844,117,000 | 1,168,855,000 | 1.81 | 0.32 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | Call | 150,000 | 150,000 | 5,419,500,000 | 5,419,500,000 | 1.68 | |
Hist
| 06/30/2023 |
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 760,904 | 183,147 | 5,356,764,000 | 538,271,000 | 1.66 | 0.40 |
Hist
| 06/30/2023 |
Terns Pharmaceuticals, Inc.
| TERN | Common | 599,668 | -68,254 | 5,247,095,000 | -2,661,101,000 | 1.62 | 1.06 |
Hist
| 06/30/2023 |
Poseida Therapeutics, Inc.
| PSTX | Common | 2,945,948 | 256,647 | 5,184,868,000 | -3,098,179,000 | 1.60 | 3.39 |
Hist
| 06/30/2023 |
Nuvalent, Inc.
| NUVL | Common | 115,067 | -166,466 | 4,852,375,000 | -2,492,821,000 | 1.50 | 0.20 |
Hist
| 06/30/2023 |
GILEAD SCIENCES, INC.
| GILD | Common | 60,448 | 318 | 4,658,727,000 | -330,259,000 | 1.44 | 0.00 |
Hist
| 06/30/2023 |
VERTEX PHARMACEUTICALS INC / MA
| VRTX | Common | 13,175 | -6 | 4,636,414,000 | 483,476,000 | 1.43 | |
Hist
| 06/30/2023 |
TELA Bio, Inc.
| TELA | Common | 416,440 | 362,344 | 4,218,537,000 | 3,642,956,000 | 1.30 | 1.70 |
Hist
| 06/30/2023 |
Viking Therapeutics, Inc.
| VKTX | COM | 258,595 | -121,405 | 4,191,825,000 | -2,135,175,000 | 1.30 | |
Hist
| 06/30/2023 |
Praxis Precision Medicines, Inc.
| PRAX | COM | 3,476,162 | 3,476,162 | 3,997,586,000 | 3,997,586,000 | 1.24 | 5.60 |
Hist
| 06/30/2023 |
Xenon Pharmaceuticals Inc.
| XENE | COM | 99,756 | 3,113 | 3,840,606,000 | 381,753,000 | 1.19 | 0.16 |
Hist
| 06/30/2023 |
Mersana Therapeutics, Inc.
| MRSN | Call | 1,100,000 | 1,100,000 | 3,619,000,000 | 3,619,000,000 | 1.12 | |
Hist
| 06/30/2023 |
Olema Pharmaceuticals, Inc.
| OLMA | Common | 390,466 | 390,466 | 3,525,908,000 | 3,525,908,000 | 1.09 | 0.96 |
Hist
| 06/30/2023 |
Sarepta Therapeutics, Inc.
| SRPT | Common | 29,860 | 20,590 | 3,419,567,000 | 2,141,883,000 | 1.06 | 0.03 |
Hist
| 06/30/2023 |
PROTHENA CORP PUBLIC LTD CO
| PRTA | Common | 49,721 | 49,721 | 3,394,950,000 | 3,394,950,000 | 1.05 | 0.09 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 91,213 | 91,213 | 3,295,526,000 | 3,295,526,000 | 1.02 | 0.16 |
Hist
| 06/30/2023 |
Mersana Therapeutics, Inc.
| MRSN | Common | 1,000,000 | 459,941 | 3,290,000,000 | 1,070,358,000 | 1.02 | 0.87 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|